Fluticasone Furoate
Brand name: Arnuity Ellipta
Rank #392 of 500 drugs by total cost
$23.7M
Total Cost
74,825
Total Claims
$23.7M
Total Cost
3,060
Prescribers
$317
Cost per Claim
7,232
Beneficiaries
96,154
30-Day Fills
$7,760
Avg Cost/Provider
24
Avg Claims/Provider
About Fluticasone Furoate
Fluticasone Furoate (sold as Arnuity Ellipta) was prescribed 74,825 times by 3,060 Medicare Part D providers in 2023, costing the program $23.7M. At $317 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 389 | Ocrelizumab (Ocrevus) | $24.2M | 639 |
| 390 | Fenofibrate (Fenofibrate) | $24.2M | 670,936 |
| 391 | Empaglifloz/Linaglip/Metformin (Trijardy Xr) | $23.9M | 28,001 |
| 392 | Fluticasone Furoate (Arnuity Ellipta) | $23.7M | 74,825 |
| 393 | Lactulose (Lactulose) | $23.6M | 538,677 |
| 394 | Siponimod (Mayzent) | $23.5M | 2,195 |
| 395 | Droxidopa (Droxidopa) | $23.4M | 9,058 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology